Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatidylinositol binding	MYO1G GBF1 ATG2A GAB2 ASAP1 ZFYVE9 PLCD1 WDFY1 TOM1L2 VPS36 PITPNM1 SNX25 AVIL	3.70e-05	316	213	13	GO:0035091
GeneOntologyMolecularFunction	phospholipid binding	MYO1G GBF1 PSD ATG2A GAB2 ASAP1 ZFYVE9 PLCD1 WDFY1 TOM1L2 CPNE9 GRK5 VPS36 PITPNM1 SYT16 SNX25 AVIL	8.66e-05	548	213	17	GO:0005543
GeneOntologyMolecularFunction	MHC class II protein complex binding	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.82e-04	27	213	4	GO:0023026
GeneOntologyMolecularFunction	MHC class II receptor activity	HLA-DRB1 HLA-DRB3 HLA-DRB5	1.85e-04	11	213	3	GO:0032395
GeneOntologyMolecularFunction	calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration	SLC8A2 SLC8A3	3.37e-04	3	213	2	GO:1905060
GeneOntologyBiologicalProcess	calcium ion homeostasis	EIF3E RYR1 RYR2 KL XCL2 PKHD1 KDR KEL PLCD1 PLCG2 XCL1 CNGB1 CACNA1A SCGN SLC8A2 SLC8A3 TRPV5	4.40e-07	389	207	17	GO:0055074
GeneOntologyBiologicalProcess	intracellular calcium ion homeostasis	EIF3E RYR1 RYR2 XCL2 PKHD1 KEL PLCD1 PLCG2 XCL1 CNGB1 CACNA1A SCGN SLC8A2 SLC8A3 TRPV5	3.71e-06	359	207	15	GO:0006874
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class II	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 PIKFYVE	1.57e-05	32	207	5	GO:0019886
GeneOntologyBiologicalProcess	MHC class II protein complex assembly	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.63e-05	16	207	4	GO:0002399
GeneOntologyBiologicalProcess	peptide antigen assembly with MHC class II protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.63e-05	16	207	4	GO:0002503
GeneOntologyBiologicalProcess	inorganic ion homeostasis	EIF3E PTK2 RYR1 RYR2 KL XCL2 PKHD1 KDR KEL PLCD1 PLCG2 ABCC2 XCL1 CNGB1 CACNA1A SCGN SLC8A2 SLC8A3 TRPV5	1.76e-05	622	207	19	GO:0098771
GeneOntologyBiologicalProcess	regulation of cytosolic calcium ion concentration	RYR1 RYR2 PLCD1 CNGB1 CACNA1A SCGN SLC8A2	2.18e-05	84	207	7	GO:0051480
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class II	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 PIKFYVE	2.84e-05	36	207	5	GO:0002495
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 PIKFYVE	3.72e-05	38	207	5	GO:0002504
GeneOntologyBiologicalProcess	MHC protein complex assembly	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	5.16e-05	21	207	4	GO:0002396
GeneOntologyBiologicalProcess	peptide antigen assembly with MHC protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	5.16e-05	21	207	4	GO:0002501
GeneOntologyBiologicalProcess	calcium ion transmembrane import into cytosol	RYR1 RYR2 XCL2 PLCD1 PLCG2 XCL1 CACNA1A SLC8A2 SLC8A3 TRPV5	7.12e-05	217	207	10	GO:0097553
GeneOntologyBiologicalProcess	mature natural killer cell chemotaxis	XCL2 XCL1	1.00e-04	2	207	2	GO:0035782
GeneOntologyBiologicalProcess	retina layer formation	FJX1 SDK2 FOXN4 CRB1	1.06e-04	25	207	4	GO:0010842
GeneOntologyBiologicalProcess	negative regulation of actin filament polymerization	SPTA1 SPTB SSH1 CARMIL1 ARFGEF1 AVIL	1.08e-04	75	207	6	GO:0030837
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 PIKFYVE	1.17e-04	48	207	5	GO:0002478
GeneOntologyBiologicalProcess	monoatomic ion homeostasis	EIF3E PTK2 RYR1 RYR2 KL XCL2 PKHD1 KDR KEL PLCD1 PLCG2 ABCC2 XCL1 CNGB1 CACNA1A SCGN SLC8A2 SLC8A3 TRPV5	1.18e-04	717	207	19	GO:0050801
GeneOntologyBiologicalProcess	positive regulation of response to tumor cell	HLA-DRB1 HLA-DRB3 XCL2 XCL1	1.67e-04	28	207	4	GO:0002836
GeneOntologyBiologicalProcess	positive regulation of immune response to tumor cell	HLA-DRB1 HLA-DRB3 XCL2 XCL1	1.67e-04	28	207	4	GO:0002839
GeneOntologyBiologicalProcess	intracellular monoatomic ion homeostasis	EIF3E PTK2 RYR1 RYR2 XCL2 PKHD1 KEL PLCD1 PLCG2 ABCC2 XCL1 CNGB1 CACNA1A SCGN SLC8A2 SLC8A3 TRPV5	1.89e-04	622	207	17	GO:0006873
GeneOntologyBiologicalProcess	establishment or maintenance of cell polarity	GBF1 PTK2 PKHD1 LRRC7 DOCK8 ARFGEF1 OOEP WDPCP CRB1 DOCK7	2.83e-04	257	207	10	GO:0007163
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous antigen	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 PIKFYVE	2.89e-04	58	207	5	GO:0019884
GeneOntologyBiologicalProcess	regulation of B cell chemotaxis	XCL2 XCL1	2.99e-04	3	207	2	GO:2000537
GeneOntologyBiologicalProcess	positive regulation of B cell chemotaxis	XCL2 XCL1	2.99e-04	3	207	2	GO:2000538
GeneOntologyBiologicalProcess	positive regulation of immunoglobulin production in mucosal tissue	XCL2 XCL1	2.99e-04	3	207	2	GO:2000558
GeneOntologyBiologicalProcess	regulation of immunoglobulin production in mucosal tissue	XCL2 XCL1	2.99e-04	3	207	2	GO:2000557
GeneOntologyBiologicalProcess	myeloid dendritic cell antigen processing and presentation	HLA-DRB1 HLA-DRB3	2.99e-04	3	207	2	GO:0002469
GeneOntologyBiologicalProcess	negative regulation of protein polymerization	SPTA1 SPTB SSH1 CARMIL1 ARFGEF1 AVIL	3.12e-04	91	207	6	GO:0032272
GeneOntologyBiologicalProcess	neuron development	PSD CUL7 DCC TENM2 RYK PTK2 ASAP1 LRIG2 KDR KEL LRRC7 CNGB1 PMP22 CACNA1A CPNE9 SYNE1 ARFGEF1 OMG WDPCP CRB1 LIFR CELSR3 IFT88 PLXNC1 TNN AVIL DOCK7 PBX2 MAPK8IP2	3.38e-04	1463	207	29	GO:0048666
GeneOntologyBiologicalProcess	nuclear migration	PTK2 CDC42BPA SYNE1 DOCK7	3.61e-04	34	207	4	GO:0007097
GeneOntologyBiologicalProcess	cell morphogenesis	SPTA1 CUL7 DCC TENM2 RYK PTK2 SSH1 PKHD1 KDR KEL PMP22 CACNA1A CPNE9 SYNE1 FOSL2 OMG WDPCP CRB1 LIFR CELSR3 IFT88 PLXNC1 TNN DOCK7 MAPK8IP2	4.05e-04	1194	207	25	GO:0000902
GeneOntologyBiologicalProcess	establishment of cell polarity	GBF1 PTK2 PKHD1 DOCK8 ARFGEF1 WDPCP CRB1 DOCK7	4.30e-04	177	207	8	GO:0030010
GeneOntologyCellularComponent	MHC class II protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.13e-05	17	210	4	GO:0042613
GeneOntologyCellularComponent	trans-Golgi network	GBF1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 KLHL20 ASAP1 BSN RIC1 ARFGEF1 IFT88 PCSK7	6.61e-05	306	210	12	GO:0005802
GeneOntologyCellularComponent	axonemal basal plate	WDPCP IFT88	1.00e-04	2	210	2	GO:0097541
GeneOntologyCellularComponent	MHC protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.24e-04	26	210	4	GO:0042611
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.06e-04	35	210	4	GO:0098553
GeneOntologyCellularComponent	Golgi apparatus subcompartment	GBF1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 KLHL20 ASAP1 BSN RIC1 ARFGEF1 PITPNM1 IFT88 PCSK7	5.70e-04	443	210	13	GO:0098791
GeneOntologyCellularComponent	autolysosome membrane	HLA-DRB1 HLA-DRB3	5.95e-04	4	210	2	GO:0120281
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.01e-06	8	208	4	PD000328
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.80e-06	9	208	4	IPR000353
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.80e-06	9	208	4	SM00921
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.80e-06	9	208	4	PF00969
Domain	MHC_II_a/b_N	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.37e-05	14	208	4	IPR014745
Domain	-	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.37e-05	14	208	4	3.10.320.10
Domain	-	IL12RB2 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 DCC LRIG2 IGSF10 LY6G6F FNDC1 PTPRB PKHD1 KDR NCR1 SDK2 MXRA5 LIFR TIE1 PLXNC1 TNN NCAN	1.71e-05	663	208	21	2.60.40.10
Domain	Ig-like_fold	IL12RB2 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 DCC LRIG2 IGSF10 LY6G6F FNDC1 PTPRB PKHD1 KDR NCR1 SDK2 MXRA5 LIFR TIE1 PLXNC1 TNN NCAN	4.30e-05	706	208	21	IPR013783
Domain	C2	OTOF PLCD1 PLCG2 RASAL2 CPNE9 WWP1 WWP2 SYT16	1.11e-04	131	208	8	PF00168
Domain	E3_ub_ligase_SMURF1	WWP1 WWP2	1.23e-04	2	208	2	IPR024928
Domain	Chemokine_XCL1/XCL2	XCL2 XCL1	1.23e-04	2	208	2	IPR008105
Domain	C2	OTOF PLCD1 PLCG2 RASAL2 CPNE9 WWP1 WWP2 SYT16	1.51e-04	137	208	8	SM00239
Domain	C2	OTOF PLCD1 PLCG2 RASAL2 CPNE9 WWP1 WWP2 SYT16	1.94e-04	142	208	8	PS50004
Domain	-	OTOF PLCD1 PLCG2 RASAL2 CPNE9 WWP1 WWP2 SYT16	2.57e-04	148	208	8	2.60.40.150
Domain	Ryanodine_rcpt	RYR1 RYR2	3.68e-04	3	208	2	IPR003032
Domain	Na_Ca_Ex	SLC8A2 SLC8A3	3.68e-04	3	208	2	IPR004836
Domain	Ryanrecept_TM4-6	RYR1 RYR2	3.68e-04	3	208	2	IPR009460
Domain	Na_Ca_Ex_C-exten	SLC8A2 SLC8A3	3.68e-04	3	208	2	IPR032452
Domain	RyR	RYR1 RYR2	3.68e-04	3	208	2	PF02026
Domain	Na_Ca_ex_C	SLC8A2 SLC8A3	3.68e-04	3	208	2	PF16494
Domain	RR_TM4-6	RYR1 RYR2	3.68e-04	3	208	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	3.68e-04	3	208	2	IPR013333
Domain	fn3	IL12RB2 DCC FNDC1 PTPRB SDK2 LIFR TIE1 TNN	4.72e-04	162	208	8	PF00041
Domain	C2_dom	OTOF PLCD1 PLCG2 RASAL2 CPNE9 WWP1 WWP2 SYT16	5.12e-04	164	208	8	IPR000008
Domain	-	GBF1 PSD ARFGEF1	5.61e-04	15	208	3	1.10.1000.11
Domain	Sec7	GBF1 PSD ARFGEF1	5.61e-04	15	208	3	PF01369
Domain	Sec7_alpha_orthog	GBF1 PSD ARFGEF1	5.61e-04	15	208	3	IPR023394
Domain	SEC7	GBF1 PSD ARFGEF1	6.85e-04	16	208	3	PS50190
Domain	Sec7	GBF1 PSD ARFGEF1	6.85e-04	16	208	3	SM00222
Domain	Sec7_dom	GBF1 PSD ARFGEF1	6.85e-04	16	208	3	IPR000904
Domain	Sec7_N	GBF1 ARFGEF1	7.30e-04	4	208	2	IPR032691
Domain	Sec7_N	GBF1 ARFGEF1	7.30e-04	4	208	2	PF12783
Domain	MHC_I/II-like_Ag-recog	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	8.20e-04	38	208	4	IPR011162
Domain	FN3	IL12RB2 DCC FNDC1 PTPRB SDK2 LIFR TIE1 TNN	1.12e-03	185	208	8	SM00060
Domain	Perilipin	PLIN5 PLIN1	1.21e-03	5	208	2	PF03036
Domain	Perilipin	PLIN5 PLIN1	1.21e-03	5	208	2	IPR004279
Pathway	BIOCARTA_TH1TH2_PATHWAY	IL12RB2 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 IL2RA	1.61e-07	23	159	6	M6705
Pathway	BIOCARTA_BBCELL_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.84e-06	11	159	4	M22030
Pathway	BIOCARTA_EOSINOPHILS_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.84e-06	11	159	4	M22048
Pathway	BIOCARTA_IL5_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.03e-05	13	159	4	M18928
Pathway	BIOCARTA_MHC_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.43e-05	14	159	4	M22023
Pathway	BIOCARTA_TCRA_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.43e-05	14	159	4	M10765
Pathway	BIOCARTA_BLYMPHOCYTE_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.43e-05	14	159	4	M1473
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.93e-05	15	159	4	M47588
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.93e-05	15	159	4	M47604
Pathway	BIOCARTA_ASBCELL_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.93e-05	15	159	4	M7298
Pathway	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 PLCG2	7.24e-05	39	159	5	M16523
Pathway	BIOCARTA_CSK_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	9.73e-05	22	159	4	M6327
Pathway	BIOCARTA_CTLA4_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	9.73e-05	22	159	4	M1467
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	RYR1 RYR2 CACNA1A	2.17e-04	11	159	3	M47958
Pathway	REACTOME_PD_1_SIGNALING	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.58e-04	28	159	4	M18810
Pathway	BIOCARTA_INFLAM_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.97e-04	29	159	4	M6910
Pathway	KEGG_ASTHMA	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	3.40e-04	30	159	4	M13950
Pathway	KEGG_HEMATOPOIETIC_CELL_LINEAGE	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 ANPEP IL2RA	4.46e-04	87	159	6	M6856
Pubmed	Allelic variation in the DR subregion of the human major histocompatibility complex.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.42e-09	4	215	4	3476943
Pubmed	Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.42e-09	4	215	4	26740600
Pubmed	HLA-DRB alleles and systemic lupus erythematosus in Jamaicans.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.42e-09	4	215	4	12144077
Pubmed	Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.42e-09	4	215	4	18520346
Pubmed	Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 IL2RA	2.12e-09	10	215	5	15784911
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 NLRP7 SPTA1 UGGT1 RGS11 DCC TEX10 RYR2 DDX5 MDN1 SACS TCHHL1 PKHD1 DLAT KDR ABCC2 BSN PLIN1 VAT1 SYNE1 GRK5 VPS36 IFT88 SETD5 SNX25 TNN AVIL CHD5 CFAP74 EIF4G3	6.52e-09	1442	215	30	35575683
Pubmed	Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	17910142
Pubmed	Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	16973583
Pubmed	Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	1970352
Pubmed	Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	7645219
Pubmed	A comparison of HLA-DR and -DQ allele and haplotype frequencies in Trinidadian populations of African, South Asian, and mixed ancestry.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	12392858
Pubmed	HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	12209103
Pubmed	HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	17182961
Pubmed	NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	11782380
Pubmed	Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	23152536
Pubmed	HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	17411376
Pubmed	Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	17507489
Pubmed	Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	7734415
Pubmed	Visual hallucinations and HLA class II antigens in cortical dementia.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	20606439
Pubmed	HLA-DR and DQB1 gene polymorphism in the North-western Colombian population.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	12144632
Pubmed	HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	7.07e-09	5	215	4	12202216
Pubmed	HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 IL2RA	1.65e-08	14	215	5	17431094
Pubmed	Association of immune responses to mycobacterium tuberculosis peptide antigens with host genetic factors.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	17153701
Pubmed	MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	18305173
Pubmed	HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	15902698
Pubmed	HLA risk markers for chronic myelogenous leukemia in Eastern Canada.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	19235017
Pubmed	A comparison of molecular HLA-DR and DQ allele profiles forming DR51-, DR52-, and DR53-related haplotypes in five ethnic Thai populations from mainland southeast Asia.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	11082517
Pubmed	Complete coding sequences and haplotypic associations of HLA-B0707, -B1524, -B4405, -B4802, -DRB10409, -DRB10411, -DRB11115, -DRB11305, and the novel allele -DRB1*0709. Group-specific amplification of cDNA from DRB1 alleles associated to DRB3 and DRB4.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	15896200
Pubmed	HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	11997714
Pubmed	HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.11e-08	6	215	4	14508706
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	KLHL28 MMP20 PTK2 KLHL20 DDX5 SSH1 CLK1 TAF1 TARS1 RC3H2 CDC42BPA WWP1 DUSP2 GRK5 SETD5 PCSK7 KDM2A BUB3 CDC25A KLHL17	3.43e-08	730	215	20	34857952
Pubmed	Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 IL2RA	3.56e-08	16	215	5	9223324
Pubmed	Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.90e-08	7	215	4	18569076
Pubmed	The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.90e-08	7	215	4	1905983
Pubmed	Human macrophages accumulate HIV-1 particles in MHC II compartments.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.90e-08	7	215	4	12230470
Pubmed	[Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis].	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.90e-08	7	215	4	18846964
Pubmed	The impact of anti-HY responses on outcome in current and subsequent pregnancies of patients with recurrent pregnancy losses.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.90e-08	7	215	4	20307907
Pubmed	Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 IL2RA	5.02e-08	17	215	5	25240755
Pubmed	Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	9.75e-08	8	215	4	19223392
Pubmed	Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	9.75e-08	8	215	4	16405603
Pubmed	HLA-A, B, Cw, DRB1, DRB3/4/5, DQB1 in German patients suffering from rapidly progressive periodontitis (RPP) and adult periodontitis (AP).	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	9.75e-08	8	215	4	12296785
Pubmed	Human leukocyte antigen class I and class II allele frequencies and HIV-1 infection associations in a Chinese cohort.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	9.75e-08	8	215	4	17106278
Pubmed	Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	9.75e-08	8	215	4	23729440
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	RYR1 RYR2 CACNA1A SLC8A2 SLC8A3 TRPV5	1.22e-07	38	215	6	30786075
Pubmed	Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.75e-07	9	215	4	24505475
Pubmed	Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.75e-07	9	215	4	23170932
Pubmed	HLA-DR genotypes influence age at disease onset in children and juveniles with type 1 diabetes mellitus.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.33e-07	3	215	3	20371654
Pubmed	Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.33e-07	3	215	3	16815190
Pubmed	Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.33e-07	3	215	3	10609818
Pubmed	Recent origin of HLA-DRB1 alleles and implications for human evolution.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	9500545
Pubmed	A novel DRB1*09 allelic sequence in the Jing ethnic minority of China.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	12121280
Pubmed	HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	19811438
Pubmed	Diversity associated with the second expressed HLA-DRB locus in the human population.	HLA-DRB3 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	9162096
Pubmed	Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	3099214
Pubmed	HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.33e-07	3	215	3	2471740
Pubmed	No gender differences in the frequencies of HLA-DRB3/B4/B5 heterozygotes in newborns and adults in Koreans.	HLA-DRB3 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	22531795
Pubmed	A novel HLA-DRB109 allele, HLA-DRB1090103*, isolated from the Han population of Guangdong, China.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	15730527
Pubmed	[Association of hemorrhagic fever with renal syndrome and HLA-DRB allele polymorphisms in Han nationality, Hubei province].	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	20193583
Pubmed	Re-evaluation of DRB10702: evidence for only one allele, DRB10701, encoding the beta chain of the HLA-DR7 antigen.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.33e-07	3	215	3	8016840
Pubmed	Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.33e-07	3	215	3	8775462
Pubmed	Identification of a novel HLA-DRB109 allele, DRB10904, in the Korean population, by sequence-based typing.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	16441501
Pubmed	Complete cDNA sequences of the HLA-DRB10402 and DRB111041 alleles.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	12358860
Pubmed	Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.33e-07	3	215	3	8462990
Pubmed	Polymorphism of HLA-DR beta chains in DR4, -7, and -9 haplotypes: implications for the mechanisms of allelic variation.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.33e-07	3	215	3	3466180
Pubmed	Mhc-DRB diversity of the chimpanzee (Pan troglodytes).	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	1428007
Pubmed	Direct sequencing of SSP-PCR-amplified cDNA to identify new alleles in the DR52-associated DRB1 group: identification of DRB11115, DRB11117 and DRB1*1319.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	7652736
Pubmed	Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	2023919
Pubmed	Shared class II MHC polymorphisms between humans and chimpanzees.	HLA-DRB1 HLA-DRB4 HLA-DRB5	2.33e-07	3	215	3	2511168
Pubmed	A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.33e-07	3	215	3	12008082
Pubmed	Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.90e-07	10	215	4	12956878
Pubmed	HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.90e-07	10	215	4	8450224
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCA2 LRWD1 GBF1 ACACA INTS1 ATG2A NCLN RYR1 MDN1 SSH1 NADK RIC1 CDC42BPA WWP1 FOSL2 GRK5 HES2 PIKFYVE CELSR3 SETD5 CHD5 PAXIP1 KLHL17	4.33e-07	1105	215	23	35748872
Pubmed	Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.53e-07	11	215	4	21085635
Pubmed	Intracellular overexpression of HIV-1 Nef impairs differentiation and maturation of monocytic precursors towards dendritic cells.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.53e-07	11	215	4	22808111
Pubmed	HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.	HLA-DRB1 HLA-DRB3 HLA-DRB4	9.28e-07	4	215	3	14677183
Pubmed	Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link.	HLA-DRB1 HLA-DRB3 HLA-DRB4	9.28e-07	4	215	3	19922436
Pubmed	Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB11501-DQB10602--positive subjects.	HLA-DRB1 HLA-DRB3 HLA-DRB4	9.28e-07	4	215	3	17002906
Pubmed	Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype.	HLA-DRB1 HLA-DRB4 HLA-DRB5	9.28e-07	4	215	3	3020127
Pubmed	HLA DR B104, 07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.	HLA-DRB1 HLA-DRB3 HLA-DRB4	9.28e-07	4	215	3	15795121
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SPTA1 SPTB SNAP47 ASAP1 DDX5 SACS DLAT LRRC7 BSN AKR1B1 TARS1 RASAL2 TOM1L2 CACNA1A DOCK8 IARS1 SYNE1 CARMIL1 ELP1 OMG PITPNM1 SLC8A2 NCAN DOCK7 EIF4G3 MAPK8IP2	9.64e-07	1431	215	26	37142655
Pubmed	HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.35e-06	14	215	4	7512597
Pubmed	Interaction of CD4 with HLA class II antigens and HIV gp120.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.35e-06	14	215	4	1869305
Pubmed	Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	22860026
Pubmed	The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	9079699
Pubmed	HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	8376762
Pubmed	Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	8168144
Pubmed	Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	7602119
Pubmed	HIV-gp120 can block CD4-class II MHC-mediated adhesion.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	1967269
Pubmed	AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	3489470
Pubmed	Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	1.84e-06	15	215	4	10729169
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DDX5 MDN1 OTOF KDR DNHD1 SDK2 CDC42BPA SYNE1 DUSP2 SNX25	2.22e-06	234	215	10	36243803
Pubmed	HLA class II amino acid epitopes as susceptibility markers of sarcoidosis.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.31e-06	5	215	3	17559577
Pubmed	Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.31e-06	5	215	3	15908298
Pubmed	The role of HLA molecules in susceptibility to chronic rheumatic heart disease.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.31e-06	5	215	3	16426242
Pubmed	HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.31e-06	5	215	3	17763415
Pubmed	Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa.	HLA-DRB1 HLA-DRB3 HLA-DRB5	2.31e-06	5	215	3	16916662
Pubmed	Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.44e-06	16	215	4	2846691
Pubmed	Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.44e-06	16	215	4	2543930
Pubmed	Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.44e-06	16	215	4	17959659
Pubmed	Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	2.44e-06	16	215	4	1978941
GeneFamily	Fibronectin type III domain containing	IL12RB2 DCC FNDC1 PTPRB SDK2 LIFR TIE1 TNN	5.21e-05	160	148	8	555
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	1.99e-04	3	148	2	287
GeneFamily	C1-set domain containing	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	3.79e-04	42	148	4	591
GeneFamily	C2 and WW domain containing	WWP1 WWP2	3.95e-04	4	148	2	838
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5	4.54e-04	44	148	4	588
GeneFamily	Perilipins	PLIN5 PLIN1	6.55e-04	5	148	2	678
GeneFamily	EF-hand domain containing\|Spectrins	SPTA1 SPTB	1.36e-03	7	148	2	1113
GeneFamily	Schlafen family	SLFN14 SLFNL1	1.36e-03	7	148	2	1110
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	ZFYVE9 WDFY1 PIKFYVE	2.04e-03	31	148	3	81
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	DCC LRIG2 IGSF10 KDR SDK2 MXRA5	2.12e-03	161	148	6	593
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	RYK KDR TIE1	4.25e-03	40	148	3	321
GeneFamily	DEAD-box helicases	DDX5 DDX43 DDX53	4.88e-03	42	148	3	499
GeneFamily	Kelch like\|BTB domain containing	KLHL28 KLHL20 KLHL17	4.88e-03	42	148	3	617
GeneFamily	Immunoglobulin like domain containing	DCC KDR NCR1 SDK2 MXRA5 TIE1	5.16e-03	193	148	6	594
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 HLA-DRB5 ASAP1 PTPRB KDR RASAL2 PMP22 SYNE1 LIFR TIE1	4.49e-08	199	213	10	14e09eaa2335d4503de50250eb4258dd5b85b304
ToppCell	kidney_cells-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 HLA-DRB5 ASAP1 PTPRB KDR RASAL2 PMP22 SYNE1 LIFR TIE1	4.70e-08	200	213	10	9f1626a7e1bd00977a5c316cafbdf654b52bad94
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 HLA-DRB5 ASAP1 PTPRB KDR RASAL2 PMP22 SYNE1 LIFR TIE1	4.70e-08	200	213	10	3007583eaad3a5ae2df010513d3e4df59155123d
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL12RB2 PVRIG XCL2 NCR1 XCL1 SYNE1 DUSP2 SYT16 TIE1	2.34e-07	181	213	9	9c4f9abb9335da2b07644bca8faff1baa1bb9f5b
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-\|bone_marrow / Manually curated celltypes from each tissue	IL12RB2 ABCA2 XCL2 PLCG2 NCR1 XCL1 FOSL2 DUSP2 TIE1	4.21e-07	194	213	9	5c58a2d1dd3c8ff77ce44d473239685e6b020909
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPB41L4A PTK2 PTPRB MAST4 KDR RASAL2 GRK5 LIFR TIE1	4.21e-07	194	213	9	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM2 RYR2 LRRC7 UNC79 RASAL2 CACNA1A SYNE1 SYT16 CHD5	4.99e-07	198	213	9	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM2 RYR2 LRRC7 UNC79 RASAL2 CACNA1A SYNE1 SYT16 CHD5	4.99e-07	198	213	9	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 HLA-DRB5 ASAP1 PTPRB KDR RASAL2 PMP22 LIFR TIE1	5.21e-07	199	213	9	e6715288a586631676722f2323f0d833431161cf
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	TENM2 RYR2 LRRC7 UNC79 RASAL2 CACNA1A SYNE1 SYT16 CHD5	5.43e-07	200	213	9	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Tracheal-10x5prime-Endothelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DRB1 HLA-DRB5 ASAP1 PTPRB KDR PMP22 GRK5 LIFR TIE1	5.43e-07	200	213	9	71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DRB1 HLA-DRB5 ASAP1 PTPRB KDR PMP22 GRK5 LIFR TIE1	5.43e-07	200	213	9	9f889f7ff0b3ba2750aa757b94680a9f7014fd0d
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DRB1 HLA-DRB5 ASAP1 PTPRB KDR PMP22 GRK5 LIFR TIE1	5.43e-07	200	213	9	06ffa5baad3e699cf66d8b2c7513649e1d2c7e62
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G IL12RB2 NCR1 BSN XCL1 DUSP2 OSBPL3 AVIL	9.69e-07	158	213	8	5d926be5a0ebe8257cd552afa7844171f9ff01c0
ToppCell	droplet-Liver-Hepatocytes-24m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL12RB2 SPTA1 SPTB RGS11 PTGER3 KEL XCL1 IL2RA	1.23e-06	163	213	8	924c666596bbb42d7876c9b164a725277f3efa5f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL12RB2 NLRP7 XCL2 PLCG2 NCR1 XCL1 FOSL2 DUSP2	2.09e-06	175	213	8	0c6cf88818037bef67211c1a8fcb1e7d47711c1d
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G IL12RB2 ADSL PVRIG NCR1 XCL1 DOCK8 DUSP2	2.27e-06	177	213	8	f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G IL12RB2 PVRIG PLCG2 NCR1 XCL1 DOCK8 DUSP2	2.37e-06	178	213	8	f914092c20130207193f97c6044ae61a9a440a86
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G IL12RB2 PVRIG PLCG2 NCR1 XCL1 DOCK8 DUSP2	2.37e-06	178	213	8	7905621f5b2aa55324c5592d1d2fef763a5fa41f
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO1G SPTA1 SPTB SLFN14 LY6G6F KEL MPP1 DOCK8	2.79e-06	182	213	8	e5e16abf4d3bd5a97e7c573b99f7a3d9a5add120
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G IL12RB2 PVRIG PLCG2 NCR1 XCL1 DOCK8 PLXNC1	2.91e-06	183	213	8	59e8d07556390828f7557ba3fd2f7d49851498b7
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G IL12RB2 PVRIG PLCG2 NCR1 XCL1 DOCK8 PLXNC1	2.91e-06	183	213	8	2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1
ToppCell	Control-Lymphocytic_NKT\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G IL12RB2 NCLN PVRIG NCR1 XCL1 DOCK8 DUSP2	3.15e-06	185	213	8	59d68e119f58b35bab36294758f6b2e25fd8f5c0
ToppCell	IIH-NK\|IIH / Condition, Cell_class and T cell subcluster	IL12RB2 SLFN14 XCL2 ACSBG2 NCR1 XCL1 DUSP2 TIE1	3.28e-06	186	213	8	cab1249b849013cf0334f25ee8d840f0521f4eb8
ToppCell	IIH-NK-\|IIH / Condition, Cell_class and T cell subcluster	IL12RB2 SLFN14 XCL2 ACSBG2 NCR1 XCL1 DUSP2 TIE1	3.28e-06	186	213	8	2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IL12RB2 ABCA2 XCL2 NCR1 XCL1 SYNE1 FOSL2 LIFR	3.28e-06	186	213	8	c984e5729958237b101df96d1c89a236faacded6
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-\|lymph-node_spleen / Manually curated celltypes from each tissue	IL12RB2 ABCA2 DDX5 XCL2 NCR1 XCL1 DUSP2 TIE1	3.41e-06	187	213	8	9000241566f48e435db9409b7255db68b68f6059
ToppCell	Healthy_donor-NK_CD56bright\|World / disease group, cell group and cell class (v2)	IL12RB2 ATG2A XCL2 NCR1 XCL1 SYNE1 DUSP2 TIE1	3.55e-06	188	213	8	8ee359199c61c3b5b498ac35148390db5cc1a836
ToppCell	Healthy_donor-NK_CD56bright\|Healthy_donor / disease group, cell group and cell class (v2)	IL12RB2 ATG2A XCL2 NCR1 XCL1 SYNE1 DUSP2 TIE1	3.69e-06	189	213	8	9eac380a3bb4b685effb52d816e1960972660646
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Control / Disease state, Lineage and Cell class	HLA-DRB1 HLA-DRB5 EPB41L4A SPOCD1 AKR1B1 RASAL2 VAT1 DOCK8	3.69e-06	189	213	8	937e876122bc4b94372a4104e9c1a9068c232018
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL12RB2 PVRIG XCL2 NCR1 XCL1 SYNE1 DUSP2 TIE1	3.69e-06	189	213	8	3e148accffc6ab249fb0dff7f3bf5a7fff9da773
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO1G IL12RB2 XCL2 PLCG2 NCR1 XCL1 DOCK8 DUSP2	3.84e-06	190	213	8	bee6a438e217b2abd57aef2a80a9fe14a298d223
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PSD SPTB TENM2 RYR2 LRRC7 BSN CELSR3 MAPK8IP2	3.84e-06	190	213	8	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PSD KL ACSBG2 BSN UNC79 CACNA1A SCGN MAPK8IP2	3.84e-06	190	213	8	5f1863bce9400b7c932f0e4d0e012ec4e8d7e555
ToppCell	Severe-Myeloid-Macrophages-FABP4+\|Severe / Condition, Lineage, Cell class and cell subclass	HLA-DRB1 HLA-DRB5 RYR1 SPOCD1 AKR1B1 CRTAP VAT1 HES2	4.15e-06	192	213	8	30aad927ad40d8abaf9d0539bf8cb9d88d16f24d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 ASAP1 PTPRB KDR RASAL2 PMP22 SYNE1 TIE1	4.48e-06	194	213	8	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-\|lymph-node_spleen / Manually curated celltypes from each tissue	IL12RB2 ABCA2 XCL2 NCR1 XCL1 FOSL2 DUSP2 TIE1	4.48e-06	194	213	8	8a596f25f6bfa5baaa2f52d80ad92f2925713398
ToppCell	COVID-19-Lymphoid-CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	HLA-DRB1 HLA-DRB5 XCL2 NCR1 XCL1 SYNE1 DUSP2 JHY	4.65e-06	195	213	8	d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|normal_Lymph_Node / Location, Cell class and cell subclass	IL12RB2 ABCA2 XCL2 NCR1 XCL1 FOSL2 DUSP2 TIE1	4.83e-06	196	213	8	00ab4a1547752d419aa720b39b94a4ab2ede963a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM2 RYR2 LRRC7 UNC79 RASAL2 SYNE1 SYT16 CHD5	4.83e-06	196	213	8	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	IL12RB2 ABCA2 XCL2 NCR1 XCL1 FOSL2 DUSP2 TIE1	4.83e-06	196	213	8	93ff94fc2b2ca8bd6a6492cbc0b402daf5d63ea2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 ASAP1 PTPRB KDR RASAL2 PMP22 SYNE1 TIE1	4.83e-06	196	213	8	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 ASAP1 PTPRB KDR RASAL2 PMP22 SYNE1 TIE1	4.83e-06	196	213	8	473980c827443464d08a0be28c53e3536369b12a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 ASAP1 PTPRB KDR RASAL2 PMP22 SYNE1 TIE1	4.83e-06	196	213	8	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RYR2 IGSF10 LRRC7 BSN PMP22 SDK2 MXRA5 SYNE1	5.01e-06	197	213	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	EPB41L4A ASAP1 PTPRB KDR RASAL2 SYNE1 LIFR TIE1	5.01e-06	197	213	8	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	HLA-DRB1 EPB41L4A ASAP1 PTPRB KDR RASAL2 SYNE1 TIE1	5.01e-06	197	213	8	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB2 DDX43 NCR1 XCL1 DUSP2 OSBPL3 AVIL	7.34e-06	148	213	7	3aa47398cb805c6c6e16b375cc3e9c7f04bb91f4
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|356C / Donor, Lineage, Cell class and subclass (all cells)	SMG1 SPTA1 SPTB CACNA1A CRB1 TIE1 KLHL17	8.01e-06	150	213	7	6bdf9df586f348641a25a445e83a41e47e7f347e
ToppCell	mild_COVID-19_(asymptomatic)-NK_CD56bright\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	IL12RB2 TMEM237 IGSF10 XCL2 XCL1 DUSP2 TIE1	8.37e-06	151	213	7	2470162f4b56bc505db166a6eb0fa54847759df8
ToppCell	COVID-19_Severe-NK_CD56bright\|World / disease group, cell group and cell class	IL12RB2 XCL2 NCR1 XCL1 DUSP2 CELSR3 TIE1	1.08e-05	157	213	7	9dcbabb377da7e93ec9f9abf09576a92877a7e02
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IL12RB2 PVRIG XCL2 NCR1 XCL1 DUSP2 SLC8A3	1.12e-05	158	213	7	607a13a3991953c1a98cc2fe90099b60487ca4f1
ToppCell	COVID-19_Severe-NK_CD56bright\|COVID-19_Severe / disease group, cell group and cell class	IL12RB2 XCL2 NCR1 XCL1 DUSP2 CELSR3 TIE1	1.17e-05	159	213	7	9e2067f0d76769717f7048dab505fadd36bbb83e
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB2 DDX43 NCR1 BSN XCL1 DUSP2 AVIL	1.49e-05	165	213	7	ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	IL12RB2 XCL2 PLCG2 NCR1 XCL1 DUSP2 TIE1	1.55e-05	166	213	7	ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYK RASAL2 VAT1 PMP22 CBLN3 WWP1 DOCK7	1.74e-05	169	213	7	780fb0050852626062a729dd1b82b0cf61e7e9ca
ToppCell	metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	MYO1G DDX5 XCL2 XCL1 VCX2 DUSP2 PCSK7	1.88e-05	171	213	7	d3e1cc1b70256c4d01488d6b6130bbcae99bdeec
ToppCell	COPD-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	IL12RB2 NLRP7 XCL2 PLCG2 NCR1 XCL1 DUSP2	2.02e-05	173	213	7	4a0043b29f8ede5a74bdb38cbf2c70e12b25e130
ToppCell	facs-Skin-nan-24m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTGER3 SACS NCR1 XCL1 PLXNC1 AVIL IL2RA	2.10e-05	174	213	7	6863222bec844f40c0c80f5c82a8ff51d1a56d0a
ToppCell	facs-Skin-nan-24m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTGER3 SACS NCR1 XCL1 PLXNC1 AVIL IL2RA	2.10e-05	174	213	7	5739c1b8d643ad360ef32049832d749c530ca603
ToppCell	facs-Skin-nan-24m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTGER3 SACS NCR1 XCL1 PLXNC1 AVIL IL2RA	2.10e-05	174	213	7	d570eab215f8287362084e37f35672e20aa0f7a2
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1G PVRIG XCL2 NCR1 XCL1 DOCK8 DUSP2	2.18e-05	175	213	7	d427c1eaea805046b1e4944d374adc7095f710a1
ToppCell	COPD-Lymphoid-ILC_A\|World / Disease state, Lineage and Cell class	IL12RB2 NLRP7 XCL2 PLCG2 NCR1 XCL1 DUSP2	2.18e-05	175	213	7	e773e330de36f8a0aa9398a176ed7edb5599c582
ToppCell	11.5-Distal-Immune-Hematopoietic,_B_Cells\|Distal / Age, Tissue, Lineage and Cell class	MYO1G HLA-DRB1 HLA-DRB5 PTGER3 LY6G6F PLCG2 DOCK8	2.18e-05	175	213	7	d8ca8fbe5309dab293c335b32f1b138edfdd0b07
ToppCell	IPF-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	IL12RB2 XCL2 PLCG2 NCR1 XCL1 DUSP2 TIE1	2.18e-05	175	213	7	b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2
ToppCell	COPD-Lymphoid-ILC_A\|COPD / Disease state, Lineage and Cell class	IL12RB2 NLRP7 XCL2 PLCG2 NCR1 XCL1 DUSP2	2.26e-05	176	213	7	484452cb38fe4604f0910a068361ed461b5b0c21
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DRB1 ATG2A XCL2 XCL1 SYNE1 FOSL2 DUSP2	2.34e-05	177	213	7	84930899eb2978598bc8a351cbcd9e714e46799d
ToppCell	Severe-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HLA-DRB1 EPB41L4A PTK2 RYR1 DDX5 PIKFYVE PLXNC1	2.43e-05	178	213	7	b7374a97c51239782bed658381a02cb1b3d9bf66
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTA1 SPTB SLFN14 ASAP1 LY6G6F CPNE9 JHY	2.43e-05	178	213	7	9e1f2596fcea5b79cc50b58d83706bb8605e224f
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD RYR1 OTOF BSN CHD5 PBX2 MAPK8IP2	2.43e-05	178	213	7	1bddbc083c36657bd6910f7466126ab325e88176
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTA1 SPTB SLFN14 ASAP1 LY6G6F CPNE9 JHY	2.43e-05	178	213	7	aa659bd283c4dfbe292cd8698bbf6b1999ca3314
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD RYR1 OTOF BSN CHD5 PBX2 MAPK8IP2	2.43e-05	178	213	7	a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTA1 SPTB SLFN14 ASAP1 LY6G6F CPNE9 JHY	2.43e-05	178	213	7	bf1d273802a4f42e52ea1bd2a0cae2039559c093
ToppCell	367C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ATG2A XCL2 PLCD1 NCR1 PORCN TIE1 JHY	2.52e-05	179	213	7	5aa8465e943b6b666c7f8b1937fcc3764bfe91f6
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1G PVRIG XCL2 NCR1 XCL1 DOCK8 IL2RA	2.52e-05	179	213	7	e717c0079b788a3703c0a450922bd5a2bdc322a0
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 PTPRB KDR RASAL2 SCGN TIE1 PLXNC1	2.61e-05	180	213	7	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	mild_COVID-19-NK_CD56bright\|mild_COVID-19 / disease group, cell group and cell class (v2)	IL12RB2 XCL2 NCR1 XCL1 FOSL2 DUSP2 TIE1	2.61e-05	180	213	7	d8b418edd807a51c0b5f4018b8b478dcc65892a7
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 PTPRB KDR RASAL2 SCGN TIE1 PLXNC1	2.61e-05	180	213	7	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP3K12 RYK ASAP1 PTPRB KDR RASAL2 TIE1	2.70e-05	181	213	7	4df7972f88117108698efd06b124b232f8588981
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL12RB2 DDX5 CLK1 XCL2 NCR1 XCL1 DUSP2	2.70e-05	181	213	7	e8c715fa3a0fed43ad4788b2d06cf45ab2c9e202
ToppCell	wk_20-22-Hematologic-Meg-ery\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SPTA1 SPTB SLFN14 LY6G6F KEL MPP1 CRB1	2.70e-05	181	213	7	d0637f9ccec5dba4997520b27287989522e04f96
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP3K12 RYK ASAP1 PTPRB KDR RASAL2 TIE1	2.70e-05	181	213	7	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	MYO1G XCL2 PLCG2 XCL1 DOCK8 OSBPL3 IL2RA	2.90e-05	183	213	7	797eb968c57e48db33ff8e2236ee22e9425c4676
ToppCell	mild_COVID-19-NK_CD56bright\|World / disease group, cell group and cell class (v2)	IL12RB2 XCL2 NCR1 XCL1 FOSL2 DUSP2 TIE1	2.90e-05	183	213	7	9a4899afac0f91203209392c5f67b3d0aa356b86
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRB KDR PLCD1 RASAL2 PORCN LIFR PLXNC1	3.11e-05	185	213	7	742350093d90f96735dc73e3360cdd749bae63fd
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL12RB2 ATG2A XCL2 NCR1 XCL1 DUSP2 TIE1	3.11e-05	185	213	7	3b2da51aec057b462749ae39afb8f253afcf38d5
ToppCell	wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DCC PTGER3 CNGB1 CRB1 CELSR3 NCAN MAPK8IP2	3.22e-05	186	213	7	72f7427d62d65e37bb0bf99229a1b75df081a128
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 OTOF NCR1 BSN CACNA1A SLC8A2 CHD5	3.22e-05	186	213	7	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	Control-Lymphoid-ILC_A\|World / Disease state, Lineage and Cell class	IL12RB2 XCL2 PLCG2 NCR1 XCL1 DUSP2 IL2RA	3.22e-05	186	213	7	7bc939bf4e71bb4c6409b862c1f6c547d775e089
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL12RB2 PVRIG XCL2 NCR1 XCL1 DUSP2 TIE1	3.22e-05	186	213	7	5ad37549592eab23f166196ebf0cb9c8ddf26082
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL12RB2 XCL2 PLCG2 NCR1 XCL1 DOCK8 DUSP2	3.33e-05	187	213	7	b5c8322ee728303425be677aa0c36fa552fd0f59
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO1G IL12RB2 XCL2 PLCG2 NCR1 XCL1 DOCK8	3.33e-05	187	213	7	9d298f43ae81d72091b31aaa6df41046d4aa31c5
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HLA-DRB1 HLA-DRB5 PTK2 PLCG2 SDK2 CARMIL1 PIKFYVE	3.33e-05	187	213	7	af1327559f7e01bec070881cae52834917c3da65
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO1G SPTA1 SPTB SLFN14 LY6G6F MPP1 DOCK8	3.44e-05	188	213	7	adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL12RB2 XCL2 PLCG2 NCR1 XCL1 DOCK8 DUSP2	3.44e-05	188	213	7	624426815b789f0f35c327b8c3c0c05ba3aa7d98
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	IL12RB2 MAST4 NCR1 DNAH9 SYNE1 GRK5 SNX25	3.44e-05	188	213	7	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-endo_bronchial_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HLA-DRB1 KL PTPRB SLC22A10 KDR PLCG2 TIE1	3.56e-05	189	213	7	4bc3826e0515b3cf2e2ef72a7b2cf9c32ade1812
ToppCell	PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	XCL2 PLCG2 NCR1 XCL1 DOCK8 OSBPL3 IL2RA	3.56e-05	189	213	7	78dcda09109a5cfb04ba069f16ec80987b3ad432
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ACACA PTK2 FOSL2 LIFR OSBPL3 SNX25 EIF4G3	3.68e-05	190	213	7	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	PSB-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IL12RB2 XCL2 NCR1 XCL1 DOCK8 DUSP2 TIE1	3.68e-05	190	213	7	e1b5d76edd4c1b95c0a7b94284a65043ab895e67
Drug	tectoridin	RYR1 RYR2 KL AKR1B1	2.33e-06	11	213	4	CID005281810
Disease	Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in)	HLA-DRB1 HLA-DRB5	4.90e-05	2	207	2	DOID:11266 (is_implicated_in)
Disease	aspirin-induced respiratory disease (is_implicated_in)	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.39e-05	11	207	3	DOID:0080822 (is_implicated_in)
Disease	self rated health	HLA-DRB1 HLA-DRB5 BSN SYT16	6.38e-05	31	207	4	EFO_0004778
Disease	C-C motif chemokine 19 measurement	HLA-DRB1 HLA-DRB5 BSN	1.17e-04	14	207	3	EFO_0008047
Disease	Colorectal Carcinoma	ACACA DCC KL SACS PKHD1 KDR ABCC2 NCR1 RASAL2 SYNE1 ARFGEF1 AKAP3 LIFR CHD5 KDM2A	1.42e-04	702	207	15	C0009402
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	1.46e-04	3	207	2	DOID:3529 (implicated_via_orthology)
Disease	acute disseminated encephalomyelitis (is_implicated_in)	HLA-DRB1 HLA-DRB5	1.46e-04	3	207	2	DOID:639 (is_implicated_in)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	1.46e-04	3	207	2	DOID:8545 (implicated_via_orthology)
Disease	breast angiosarcoma (is_implicated_in)	PTPRB KDR	1.46e-04	3	207	2	DOID:4511 (is_implicated_in)
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	PKHD1 IFT88 CDC25A	1.78e-04	16	207	3	DOID:0110861 (implicated_via_orthology)
Disease	response to interferon-beta, anti-drug antibody measurement	HLA-DRB1 HLA-DRB5 CCHCR1	2.15e-04	17	207	3	EFO_0010559, GO_0035456
Disease	Hereditary elliptocytosis	SPTA1 SPTB	2.91e-04	4	207	2	cv:C0013902
Disease	lymphotactin measurement	XCL2 XCL1	2.91e-04	4	207	2	EFO_0008214
Disease	bacterial infectious disease (is_implicated_in)	HLA-DRB1 DOCK8	2.91e-04	4	207	2	DOID:104 (is_implicated_in)
Disease	left ventricle sphericity index	CEP85L HLA-DRB5	2.91e-04	4	207	2	EFO_0020938
Disease	platelet component distribution width	MYO1G SPTA1 SLFN14 GAB2 ASAP1 ZNF490 N4BP2L2 PLCG2 DOCK8 SYNE1 CARMIL1 GRK5 SCGN TNN DOCK7	3.08e-04	755	207	15	EFO_0007984
Disease	hereditary spherocytosis (is_implicated_in)	SPTA1 SPTB	4.83e-04	5	207	2	DOID:12971 (is_implicated_in)
Disease	lactic acidosis (implicated_via_orthology)	DLAT TRMT5	4.83e-04	5	207	2	DOID:3650 (implicated_via_orthology)
Disease	Hereditary spherocytosis	SPTA1 SPTB	4.83e-04	5	207	2	cv:C0037889
Disease	post-operative stroke, response to surgery	BBS9 RYR2	4.83e-04	5	207	2	EFO_0009951, EFO_0009956
Disease	Anemia, hereditary spherocytic hemolytic	SPTA1 SPTB	4.83e-04	5	207	2	C0221409
Disease	brain glioma (is_marker_for)	PTPRB KDR	4.83e-04	5	207	2	DOID:0060108 (is_marker_for)
Disease	hepatocyte nuclear factor 4-alpha measurement	HLA-DRB1 HLA-DRB5	4.83e-04	5	207	2	EFO_0801672
Disease	Elliptocytosis, Hereditary	SPTA1 SPTB	7.21e-04	6	207	2	C0013902
Disease	extranodal nasal NK/T cell lymphoma	HLA-DRB1 HLA-DRB3	7.21e-04	6	207	2	MONDO_0019472
Disease	unipolar depression, bipolar disorder	MYO1G DCC TENM2 SYNE1 OSBPL3 NCAN	8.42e-04	156	207	6	EFO_0003761, MONDO_0004985
Disease	depressive symptom measurement	DCC PTGER3 TENM2 PKHD1 CACNA1A CARMIL1 SCGN WDPCP CRB1 EIF4G3	9.11e-04	426	207	10	EFO_0007006
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	BSN CELSR3	1.00e-03	7	207	2	EFO_0020797
Disease	Ciliopathies	TMEM237 BBS9 PKHD1 WDPCP CRB1	1.09e-03	110	207	5	C4277690
Disease	phospholipids:total lipids ratio	PSD HLA-DRB1 HLA-DRB5 SCGN NCAN DOCK7 PCSK7	1.16e-03	227	207	7	EFO_0020946
Disease	Hereditary spherocytosis	SPTA1 SPTB	1.33e-03	8	207	2	C0037889
Disease	cerebellar ataxia (implicated_via_orthology)	AARS2 CACNA1A	1.33e-03	8	207	2	DOID:0050753 (implicated_via_orthology)
Disease	interleukin-21 measurement	HLA-DRB1 HLA-DRB5	1.33e-03	8	207	2	EFO_0801724
Disease	susceptibility to childhood ear infection measurement	HLA-DRB1 TENM2 BSN ELP1 WDPCP SLC8A3	1.35e-03	171	207	6	EFO_0007904
Disease	lymphocyte measurement	MYO1G HLA-DRB1 HLA-DRB5 CBLN3 IL2RA	1.44e-03	117	207	5	EFO_0803546
Disease	smoking status measurement	GBF1 DCC SLFN14 PTGER3 TENM2 PTK2 RYR2 GAB2 PKHD1 SETD3 UNC79 DMAC1 TOM1L2 MMS22L CDC42BPA WWP2 WDPCP EIF4G3	1.44e-03	1160	207	18	EFO_0006527
Disease	immature platelet measurement	MYO1G SLFN14 ASAP1 DOCK8 CARMIL1	1.55e-03	119	207	5	EFO_0803541
Disease	Malignant neoplasm of breast	XIRP1 CEP85L OTOF NFYC KDR LRRC7 SPOCD1 DNAH9 RASAL2 SYNE1 ELP1 NUDT17 SLC8A3 CHD5 SLC6A5 PUS1 UQCC1	1.58e-03	1074	207	17	C0006142
Disease	Epstein Barr virus nuclear antigen 1 IgG measurement	HLA-DRB1 HLA-DRB5	1.71e-03	9	207	2	EFO_0007790
Disease	survival time	XCL2 XCL1	1.71e-03	9	207	2	EFO_0000714
Disease	Autosomal Recessive Polycystic Kidney Disease	PKHD1 IFT88	1.71e-03	9	207	2	C0085548
Disease	central nervous system non-hodgkin lymphoma	HLA-DRB1 HLA-DRB5	1.71e-03	9	207	2	MONDO_0044887
Disease	HLA class II histocompatibility antigen, DQ alpha 2 chain measurement	HLA-DRB1 HLA-DRB5	1.71e-03	9	207	2	EFO_0801686
Disease	response to vaccine	HLA-DRB1 HLA-DRB3 HLA-DRB5 DNAH9 RASAL2	1.73e-03	122	207	5	EFO_0004645
Disease	bullous pemphigoid	HLA-DRB1 HLA-DRB5 MAST4	1.73e-03	34	207	3	EFO_0007187
Disease	pursuit maintenance gain measurement	MYO1G SDK2 CARMIL1 LIFR OSBPL3	1.79e-03	123	207	5	EFO_0008433
Disease	platelet measurement	SLFN14 GAB2 ASAP1 PLCG2 DOCK8 CARMIL1 SLC8A3 DOCK7	1.80e-03	315	207	8	EFO_0005036
Disease	white matter microstructure measurement	DCC TENM2 MAST4 SDK2 SCGN CRB1 TIE1 UQCC1 EIF4G3	1.83e-03	390	207	9	EFO_0005674
Disease	Drug Allergy	HLA-DRB1 PTGER3 ABCC2	1.89e-03	35	207	3	C0013182
Disease	interleukin 4 measurement	LRIG2 FNDC1 CARMIL1	2.05e-03	36	207	3	EFO_0008184
Disease	CCL19 measurement	HLA-DRB1 HLA-DRB5	2.12e-03	10	207	2	EFO_0009415
Disease	Berylliosis	HLA-DRB1 IL2RA	2.58e-03	11	207	2	C0005138
Disease	Beryllium Disease	HLA-DRB1 IL2RA	2.58e-03	11	207	2	C2350873
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	PKHD1 CDC25A	2.58e-03	11	207	2	DOID:0110861 (biomarker_via_orthology)
Disease	alpha angle measurement	GRK5 UQCC1	2.58e-03	11	207	2	EFO_0020071
Disease	alcohol use disorder (implicated_via_orthology)	PSD RYR1 RYR2 SSH1 UNC79 GRK5	2.62e-03	195	207	6	DOID:1574 (implicated_via_orthology)
Disease	venous thromboembolism, response to antineoplastic agent	RYK PKHD1 RIC1	2.98e-03	41	207	3	EFO_0004286, GO_0097327
Disease	killer cell immunoglobulin-like receptor 2DL4 measurement	SLFN14 NCR1	3.09e-03	12	207	2	EFO_0008197
Disease	thyroid gland carcinoma (is_marker_for)	PTPRB KDR	3.09e-03	12	207	2	DOID:3963 (is_marker_for)
Disease	anti-Epstein Barr virus antibody measurement	HLA-DRB1 HLA-DRB5	3.09e-03	12	207	2	EFO_0009273
Disease	serum iron measurement	ASAP1 PLCG2 CARMIL1 SCGN	3.19e-03	86	207	4	EFO_0006332
Disease	cholesteryl esters to total lipids in small LDL percentage	HLA-DRB1 NCAN DOCK7	3.19e-03	42	207	3	EFO_0022255
Disease	grip strength measurement	GBF1 HLA-DRB1 HLA-DRB5 UNC79 MMS22L WWP2 IFT88 OSBPL3	3.44e-03	350	207	8	EFO_0006941
Disease	hypothyroidism	IL12RB2 HLA-DRB1 HLA-DRB3 LRIG2 KCTD19 PLXNC1 IL2RA	4.06e-03	284	207	7	EFO_0004705
Disease	obsolete aging, epigenetic status	PKHD1 CARMIL1 SCGN	4.14e-03	46	207	3	EFO_0000473, GO_0007568
Disease	Eczema, allergic rhinitis	HLA-DRB1 HLA-DRB3 TCHHL1 CCHCR1 FOSL2 IL2RA	4.22e-03	215	207	6	EFO_0005854, HP_0000964
Disease	tuberculosis	DPY19L3 C5orf22 HLA-DRB1 HLA-DRB5 ASAP1 SLC8A3	4.32e-03	216	207	6	MONDO_0018076
Disease	Opioid use measurement	NLRP7 NCR1	4.84e-03	15	207	2	EFO_0009937
Disease	anti-anoctamin 2 antibody measurement	HLA-DRB1 HLA-DRB5	6.21e-03	17	207	2	EFO_0010150
Disease	Bardet-Biedl syndrome 1 (disorder)	BBS9 WDPCP	6.21e-03	17	207	2	C2936862
Disease	acute graft vs. host disease	HLA-DRB3 PTK2 DMAC1	6.49e-03	54	207	3	EFO_0004599
Disease	vital capacity	HLA-DRB1 DCC TENM2 RYR2 DDX5 NADK KDR HMGCLL1 DMAC1 TOM1L2 MMS22L SYNE1 WWP2 GRK5 AGPS UQCC1 KDM2A	6.51e-03	1236	207	17	EFO_0004312
Disease	ecosanoids measurement	SLC22A10 GML ABCC2	6.83e-03	55	207	3	EFO_0020044
Disease	risky sexual behaviour measurement	DCC TENM2 MMS22L GRK5 WDPCP	6.93e-03	169	207	5	EFO_0007877
Disease	late-onset myasthenia gravis	HLA-DRB1 HLA-DRB5	6.96e-03	18	207	2	EFO_1001490
Disease	Bardet-Biedl syndrome	BBS9 WDPCP	6.96e-03	18	207	2	cv:C0752166
Disease	Hemangiosarcoma	PTPRB KDR	6.96e-03	18	207	2	C0018923
Disease	disease free survival	CCDC168 XCL1	6.96e-03	18	207	2	EFO_0000409

Protein segments in the cluster

Peptide	Gene	Start	Entry
INEILPNWEVMRSTR	TBC1D12	461	O60347
VDMNKTEVTPRLWTT	ACSBG2	16	Q5FVE4
ESPSWVTQRAQEMFQ	CACNA1A	2026	O00555
LNPTDVMLLDTWDQV	AVIL	641	O75366
PWTITQMVIGLSENQ	DMAC1	81	Q96GE9
APLSTIINWEREFEM	CHD5	756	Q8TDI0
IQVPEASVTIDLEMW	CREB3L3	141	Q68CJ9
WTSRPDQALLASMNT	ADGRG4	656	Q8IZF6
PEQQTEKAEWMTTTC	ARFGEF1	1441	Q9Y6D6
SEIMQPWAQTVVVGR	ACACA	1961	Q13085
PEVNVMVTGSWDQTV	BUB3	106	O43684
QLPTTVRDIMNRWTL	ANPEP	531	P15144
PDTVELMNWINSNTP	DPY19L3	556	Q6ZPD9
NVWQARVSSMPIELL	DNHD1	751	Q96M86
IWSVNEVLESMESPL	ATG2A	56	Q2TAZ0
ESWVQTVLPLVMDIQ	ALG1L	146	Q6GMV1
VVPSDTNILDTWAAM	AKR1B1	131	P15121
TDPNSTFRCVQMLEW	CLK1	216	P49759
AVSPTWEQLENAMVA	RC3H2	366	Q9HBD1
WVNIDSRTMEQTLEG	RGS11	366	O94810
QAEWRPDSTMIAVST	RIC1	71	Q4ADV7
LAPMDVLNEWTAEIT	KCTD19	376	Q17RG1
QLDSVMDWLTNQPRA	NCLN	451	Q969V3
PESLSEFTQWRVRMI	LRWD1	181	Q9UFC0
CSVVPSRRMDSVTWQ	LY6G6F	146	Q5SQ64
EMIATWSPAVRTLRN	PAXIP1	326	Q6ZW49
TRRGEMETLEPNNLW	DCC	666	P43146
QMLSESVLPEWTIRE	PTPRB	1831	P23467
MESNQTWITEVILLG	OR2A12	1	Q8NGT7
PREMRANGSWQEAVT	PBX2	396	P40425
MVTTTTDWNQPAEAQ	KIAA0100	1681	Q14667
NEVNPEVWMNTSEII	LIPN	26	Q5VXI9
WVERTQQLQDISSML	MDN1	3101	Q9NU22
PQRSWFLRQMELDTT	PIP5KL1	256	Q5T9C9
DWTFQTLVMLETVPR	HLA-DRB5	181	Q30154
VRASPDSWLTQIMEQ	JHY	556	Q6NUN7
WSEPSNLLDLVVTEM	NCR1	106	O76036
MEIIQLASLDSDPWV	NELFA	76	Q9H3P2
RQASSQSMPWLADLV	INTS1	881	Q8N201
NEVSALMWLTPDVAA	NUDT17	206	P0C025
QQELRTVSMTAWKPR	LRRC37A5P	81	Q49AS3
PTLWEEQRQQRMTVA	LRRC7	446	Q96NW7
EMTVRFLQELPASSW	HES2	61	Q9Y543
NEEMVQRQTIWTLLS	MMS22L	611	Q6ZRQ5
FTVSSNEMSWIRQAP	IGHV3-38	46	A0A0C4DH36
SILISWNSIPVQEQM	IL12RB2	536	Q99665
DSPWLLSNLVSRMIS	MAPK8IP2	346	Q13387
VWQESSQEAPFMVIT	BSN	1546	Q9UPA5
VDQIRPDRQTLMWSA	DDX5	266	P17844
TQIIPTAQETWMALR	CPA5	411	Q8WXQ8
VSPSVADMLEWLQDI	C1orf109	131	Q9NX04
SIPVEDNQMVEISAW	DUSP2	221	Q05923
LDELPWSAMTNDEQV	FAM199X	176	Q6PEV8
TIMHIQDPASQRLTW	NADK	86	O95544
QSPRSLEVLWNVSRM	PCSK7	501	Q16549
WPSMARIAQSTEVLF	PLXNC1	261	O60486
VDQRSREVLQMWSVL	KPTN	231	Q9Y664
VPEANSSWMDTVIRQ	DLAT	491	P10515
AQWGRITTETAIQLM	PTGER3	271	P43115
SLPMLVRQLWDSAVS	PEX26	231	Q7Z412
ELVQAMRWDQASDRP	CUL7	306	Q14999
EKISQTAPEWTAQAM	COPS4	386	Q9BT78
TLVSTPEQEQLMVVW	INTS2	441	Q9H0H0
ATMSPVERTAAWVLN	RASAL2	951	Q9UJF2
MERSLPEIWTLTYQQ	ELP1	1266	O95163
TLNWLVRMTSEIETN	ABCC2	1251	Q92887
RTVQVIMETRQVAWS	PLCG2	41	P16885
QEAMNASTPTIIESW	PLCG2	131	P16885
QQSLQSFWPRVMEEI	NFYC	16	Q13952
VWPMTEREDDLNVSV	BBS9	401	Q3SYG4
IWQESRKVMRTPESQ	PLCD1	51	P51178
WSMEPVVRRLSTQFT	PLIN1	71	O60240
DRAIIPEMEWTSQAL	OOEP	66	A6NGQ2
PEMEWTSQALLTVDI	OOEP	71	A6NGQ2
NVELPRSMVEVVTSW	PORCN	291	Q9H237
SLQWDPRVMQRATSN	FJX1	311	Q86VR8
QVTPVVALSNESWSM	PIKFYVE	1321	Q9Y2I7
SSLVQMQWIAPQVVS	WDPCP	436	O95876
DWTFQTLVMLETVPR	HLA-DRB3	181	P79483
DLRADPSWLMQDQIS	IGSF10	421	Q6WRI0
ENPSQAIEWLMQVVS	IFT88	566	Q13099
QVNVWSPVASMLSRR	KLHL17	506	Q6TDP4
TNQWSPVVAMTSRRS	KLHL20	531	Q9Y2M5
MVQRPSTVDFIDWVD	KDM2A	156	Q9Y2K7
PDTNTWTSLERMNES	KLHL28	361	Q9NXS3
QTSPDLRLTWLQNMA	DOCK7	1681	Q96N67
ASPDLRLTWLQNMAE	DOCK8	1636	Q8NF50
SDAQEMETVWTILPA	MT-CO2	56	P00403
PQLEWQMETTQSLVD	DNM1P34	26	Q6PK57
NWRTSITDMELALPD	CRTAP	221	O75718
MSSQSVLVSWVDPVL	FNDC1	271	Q4ZHG4
ETVQRWASNPGMESL	C5orf22	321	Q49AR2
PMVVLYTQSRASQEW	CPNE9	36	Q8IYJ1
DWTFQTLVMLETVPR	HLA-DRB1	181	P01911
TSQDLQWMVQPTVIT	FOSL2	56	P15408
WARTPRLSVMEEDQA	ABCA2	951	Q9BZC7
QPSVRTQMWLTEQLR	CEP85L	291	Q5SZL2
TQMWLTEQLRTNPLE	CEP85L	296	Q5SZL2
SLWNRMPDQISVSEF	ASAP1	16	Q9ULH1
LDTQRPQVTMWERDV	CCHCR1	51	Q8TD31
PQVTMWERDVSSDRQ	CCHCR1	56	Q8TD31
NMTPEEAERWIVNLI	EIF3E	361	P60228
DWTFQTLVMLETVPR	HLA-DRB4	181	P13762
LSRTMQLVELANETW	BRF2	201	Q9HAW0
RWTQPQLICTGEMET	IL2RA	176	P01589
ELTSSQRWPQSLNMR	MAP3K12	731	Q12852
WPASAETSNLVRMRS	MAST4	186	O15021
SMQQILPIVWNTLTE	IPO9	286	Q96P70
LLTIPMDNTEVAQWL	GBF1	726	Q92538
MDNTEVAQWLRENPR	GBF1	731	Q92538
QEMTDITWLNSPSQV	KL	831	Q9UEF7
ISQAREAMLQITEWR	C2orf81	86	A6NN90
SMEPSERLASLQALW	CARMIL1	131	Q5VZK9
DVRPDRQTVMTSATW	DDX53	396	Q86TM3
RQTVQVSLMLNTWPV	CBLN3	136	Q6UW01
PELQEWRVASMAQSA	MPP1	221	Q00013
TTPWRNINVEAMELE	DNAH9	1321	Q9NYC9
KQRDQSEPVWDMTTQ	CCDC168	6291	Q8NDH2
TVRLENMWQERFLSP	CELSR3	1276	Q9NYQ7
SQTSRWQMEVDNETP	CRB1	1046	P82279
SVSIPWQNEMIETEC	GRK5	506	P34947
RIRQENDMVDSAPQW	EPB41L4A	501	Q9HCS5
NDMVDSAPQWEAVLR	EPB41L4A	506	Q9HCS5
ENPLDSSVEFMQIWR	SCGN	101	O76038
ILEMSENNAPWTVLL	SDK2	626	Q58EX2
RSDWNNSLMTALIAP	SACS	2906	Q9NZJ4
NENRPVRWMALESLV	RYK	501	P34925
ISETNRAQWEMPQVK	RYR1	4196	P21817
STLQQLISETMVRWA	RYR2	2056	Q92736
LISETMVRWAQESVI	RYR2	2061	Q92736
ELPLVAASATMRAQW	GML	11	Q99445
DWVEANLDEIQMSSP	EIF4G3	1446	O43432
DVRPDRQTVMTSATW	DDX43	416	Q9NXZ2
ETRVLEAPMTIWVAD	CFAP74	886	Q9C0B2
RAEWRQMNNIPLVSE	KBTBD6	541	Q86V97
LMDWRKVPSNSTETV	LIFR	671	P42702
WTAPLVMRTTNLDNR	CDC25A	241	P30304
TEVLNETLCPTWDQM	OTOF	996	Q9HC10
ETRVPLWLQSSEDME	OSBPL3	206	Q9H4L5
AVEMALQAWSSAVPL	MMP20	141	O60882
IEVTSFVSSRWVPQM	HMGCLL1	116	Q8TB92
NTMQEWTDVRQSSEP	GAB2	656	Q9UQC2
LSWLTAVDVPRLQQM	FOXN4	46	Q96NZ1
TREARIQTLEPDNWM	RSAD1	316	Q9HA92
EVVTPNIFNSRLWMT	TARS1	371	P26639
IPVAWTSLTQMLLEA	TRMT5	31	Q32P41
PDSWIMKDNSVTRLT	SLFN14	326	P0C7P3
APSLEQMQSWITRIN	PSD	851	A5PKW4
VQWLELSEAVLPTMT	TMCO4	71	Q5TGY1
GPWRTQTQEQMSRDV	SNAP47	36	Q5SQN1
LEPRTTAAMWALQTV	TMEM205	106	Q6UW68
SMWSPEEQDRTNLQV	SYT16	326	Q17RD7
WTQQSVTVPQELEMV	SYNE1	6821	Q8NF91
LERNNTPVVGWVNMS	SLC6A5	141	Q9Y345
QIRDTVSWIFSEQML	SNX25	721	Q9H3E2
ERDERSMAQWLSTLP	PUS1	381	Q9Y606
MIIISNNSLPITEWI	SLC22A10	211	Q63ZE4
MKIDDEVRTAPWNTT	TAF1	921	P21675
IAMWQPNVEDSTVLD	PTK2	781	Q05397
QSRSPWADLTNEVDM	NCAN	536	O14594
MDPLQTASVQWFERT	ADSL	316	P30566
RLEEISPWLAAMTNT	SMG1	2091	Q96Q15
MSEIRFTNLTWDQVI	TENT5D	1	Q8NEK8
MWPQSLSELVLSEAS	SATL1	331	Q86VE3
WAVSSVMTRQNQIPT	SETD3	246	Q86TU7
NISSRWMVPTSVERL	SETD5	1161	Q9C0A6
SMDVAQVRLEWPTDL	TENM2	1406	Q9NT68
MTSPQLEWTLQTLLE	NLRP7	1	Q8WX94
LTVAMATEQLLESWP	PKHD1	1821	P08F94
RESPNITDRWILSFM	IARS1	686	P41252
DIFDVNSMEWIQTLP	CDC42BPA	1471	Q5VT25
SEMPQQSTTLNLWRE	OMG	391	P23515
RLIEAVETAVMPQWQ	AARS2	826	Q5JTZ9
RSVQTQVSEPFMESW	SLFNL1	6	Q499Z3
IRLWQLIMATPEENS	STRA8	16	Q7Z7C7
INEWNAMQDLESTRP	SSH1	221	Q8WYL5
QAQDWKMDTSTDPVR	AKAP3	26	O75969
ISLDTSQMNRILWVD	AGPS	256	O00116
EISEMNSPSRRVLTW	CNGB1	91	Q14028
NIDVSMDVKPSWTTR	TMEM237	201	Q96Q45
SPQSLSEWRMQNIAR	PITPNM1	326	O00562
DPQATWVRDVVRSMD	XCL1	71	P47992
DPQATWVRDVVRSMD	XCL2	71	Q9UBD3
KLTMNPNWTVRSDSE	WFDC3	211	Q8IUB2
QSRVQPMTASNWTLV	TMX4	36	Q9H1E5
WEIPRESLTQEQRMF	ZNF189	116	O75820
NTRTTQWEDPRTQGM	WWP2	426	O00308
ETESMLLNETVPQWV	WDR48	536	Q8TAF3
MTQRRWENMPVSQSL	VPS36	126	Q86VN1
MERPLEEQVQSKWSS	ZNF490	11	Q9ULM2
QESEVEEPLTVWMAS	VCX2	116	Q9H322
VTENMATVSWDPVQA	TNN	631	Q9UQP3
TDRVTENMATVSWDP	TNN	716	Q9UQP3
ENMATVSWDPVRATI	TNN	721	Q9UQP3
VTENMATVSWDPVQA	TNN	896	Q9UQP3
MDWSTIVVDPSENVT	TIE1	491	P35590
SSMQLAPQELARWRD	SPOCD1	696	Q6ZMY3
SMLEQKRDPWTLQSE	ZNF534	71	Q76KX8
SWRLMQIQPNREDTE	TEX10	486	Q9NXF1
LSWMESIIRQIETQE	SPTB	1916	P11277
QVESWMVARENSLRS	SPTA1	1406	P02549
QDEMWTAVRALQLTS	SMCO1	56	Q147U7
RALSRTSQWPQMSQS	UQCC1	36	Q9NVA1
WDVTVRDLLPSSAMI	nan	376	Q6ZUG5
EVESPQWEIMESLTS	ZNF582	96	Q96NG8
VSPIERNEQLWIMTT	ZNF226	56	Q9NYT6
MLQTTWPQESVTFED	ZNF621	1	Q6ZSS3
VLNRSGMWQEEVTVP	VAT1	136	Q99536
RADMSWQQETNPVVE	ZNF215	26	Q9UL58
QPDMQPTEQESVSLW	KDR	556	P35968
MSEEEAAQIPRSSVW	PLIN5	1	Q00G26
SSVPWSSLEKQMQRD	TCHHL1	771	Q5QJ38
TTTWQRPTMESVRNF	WWP1	406	Q9H0M0
RPTMESVRNFEQWQS	WWP1	411	Q9H0M0
QPSVMDDIEVWLRTD	TOM1L2	431	Q6ZVM7
TPEVWVQVRMEATEL	PVRIG	41	Q6DKI7
SSPNEWLQSVQATMI	PMP22	56	Q01453
VQTIRWLFETCPMSE	XIRP1	591	Q702N8
IAVWNMDVSREEAPQ	WDFY1	266	Q8IWB7
LNPEIATMWIDENAV	ZFYVE9	96	O95405
TLNLNTPESWMVESV	UGGT1	1071	Q9NYU2
ELWRAQVVATTVMLE	TRPV5	591	Q9NQA5
EFWSRVTPSILQLMA	UNC79	2511	Q9P2D8
RMLSSVSEDTVLWNP	ZNF641	206	Q96N77
ITRLRNLPWMNEETQ	KEL	451	P23276
TQMSGETLQRPVWNI	LRIG2	986	O94898
VRIWNETVSNLTLMA	SLC8A2	121	Q9UPR5
IRVWNETVSNLTLMA	SLC8A3	126	P57103
RAMWPDGQQDITEVT	MYO1G	556	B0I1T2
WVMIEPSGAVQRDQT	MXRA5	476	Q9NR99
SPVIIDNTNIQAWEM	N4BP2L2	471	Q92802